In addition to the decrease in CYFIP1 and WASF2 gene copy numbers in tumor samples, the copy number of other DGs increased to varying degrees, consistent with the decline in CYFIP1 and WASF2 gene expression in BC patients. Here, WASF2 is linked to breast cancer.